Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsBrittany Craiglow, MD
Associate Professor Adjunct - DermatologyAbout
Research
Publications
2026
Heterozygous variants in DOCK2 leading to susceptibility to viral illnesses
Al-Musa A, Platt C, Elkins M, Novak T, Woods B, Bourdine A, Magin L, Craiglow B, Newhams M, Kong M, Randolph A, Chou J. Heterozygous variants in DOCK2 leading to susceptibility to viral illnesses. The Journal Of Allergy And Clinical Immunology 2026 PMID: 41654261, PMCID: PMC13016768, DOI: 10.1016/j.jaci.2026.01.026.Peer-Reviewed Original ResearchInborn errors of immunityErrors of immunityHeterozygous variantsInborn errorsHealthy individualsIFN-a therapyAntiviral immunitySoft tissue infectionsHuman papilloma virusHeterozygous pathogenic variantsCohort of patientsImpaired antiviral immunityRespiratory syncytial virusToll-like receptor signalingAged 3 monthsAutosomal-recessive diseaseSusceptibility to infectionRefractory wartsRecurrent infectionsPapilloma virusDOCK2 deficiencySyncytial virusSevere acute respiratory syndrome coronavirus 2Severe infectionsViral illness
2025
Successful Treatment of Alopecia Areata With One JAK Inhibitor After Failure of Other JAK Inhibitors
Kalil L, Craiglow B, King B. Successful Treatment of Alopecia Areata With One JAK Inhibitor After Failure of Other JAK Inhibitors. JAMA Dermatology 2025, 161: 1285-1287. PMID: 41060634, PMCID: PMC12509074, DOI: 10.1001/jamadermatol.2025.3537.Peer-Reviewed Original ResearchDiscontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
Ogbutor C, Chen L, Kalil L, Kelley K, Craiglow B, King B, Senna M. Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series. International Journal Of Women's Dermatology 2025, 11: e218. PMID: 40810112, PMCID: PMC12348381, DOI: 10.1097/jw9.0000000000000218.Peer-Reviewed Original ResearchTreatment of Short Anagen Syndrome With Low‐Dose Oral Minoxidil
Francis N, Craiglow B. Treatment of Short Anagen Syndrome With Low‐Dose Oral Minoxidil. Pediatric Dermatology 2025, 43: 220-221. PMID: 41001993, DOI: 10.1111/pde.70049.Peer-Reviewed Original ResearchStatement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
Meah N, Li J, Wall D, York K, Bhoyrul B, Bokhari L, Coulthard L, Asfour L, Abraham L, Asz‐Sigall D, Bergfeld W, Betz R, Blume‐Peytavi U, Callender V, Chitreddy V, Combalia A, Cotsarelis G, Craiglow B, Dhurat R, Dlova N, Donovan J, Doroshkevich A, Eisman S, Farrant P, Gadzhigoroeva A, Green J, Grimalt R, Harries M, Hordinsky M, Irvine A, Jolliffe V, Kaiumov S, King B, Kossard S, Lee J, Lee W, Lortkipanidze N, McMichael A, Mesinkovska N, Messenger A, Mirmirani P, Olsen E, Orlow S, Ovcharenko Y, Piraccini B, Pirmez R, Rakowska A, Reygagne P, Roberts J, Rudnicka L, Saceda‐Corralo D, Shapiro J, Sharma P, Silyuk T, Suchonwanit P, Takwale A, Tosti A, Visser W, Vañó‐Galván S, Vogt A, Wade M, Yip L, Zlotogorski A, Zhou C, Sinclair R. Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024. Journal Of The European Academy Of Dermatology And Venereology 2025, 40: 210-223. PMID: 40698981, PMCID: PMC12843854, DOI: 10.1111/jdv.20833.Peer-Reviewed Original ResearchFrontal fibrosing alopeciaPrognostic indicatorIncidence of frontal fibrosing alopeciaOptimal treatment algorithmEvidence-based treatment recommendationsThree-round Delphi processInternational consensus statementSystemic therapyTreatment algorithmTreatment modalitiesPhysical therapyTreatment recommendationsConsensus statementDelphi processRobust researchExpert consensusConsensus thresholdDisease monitoringConsensus agreementTherapyCOLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
O'Connor C, Boyle A, Asfour L, Bhoyrul B, Bokhari L, Cotsarelis G, Cotter C, Craiglow B, Cutlar L, Dhurat R, Dlova N, Doche I, Donovan J, Drucker A, Eisman S, Melo D, Harries M, Hordinsky M, Kazmi A, King B, Kolios A, Meah N, Mirmirani P, Mostaghimi A, Ohyama M, Ovcharenko Y, Pirmez R, Piraccini B, Rudnicka L, Saceda‐Corralo D, Shapiro J, Sibbald C, Sinclair R, Smith B, Starace M, Vaño‐Galván S, Koh W, York K, McDonald I, Wall D. COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists. JEADV Clinical Practice 2025, 4: 811-820. DOI: 10.1002/jvc2.70067.Peer-Reviewed Original ResearchJanus kinase inhibitorsComplete blood countAlopecia areataSystemic therapySeverity of Alopecia ToolConventional systemic therapiesThyroid function testsComplete blood count testDermatology Life Quality IndexNon-scarring alopeciaLife Quality IndexLaboratory testsHair loss disorderHair specialistThrombophilia screeningLaboratory testing practicesCoagulation profileTreating AAHair expertsHepatitis BThyroid functionAutoimmune conditionsBlood countBlood testsKinase inhibitorsUnderstanding eyebrow and eyelash involvement in patients with alopecia areata and responsiveness to treatment with baricitinib
Mostaghimi A, Craiglow B, King B, Shapiro J, Ko J, Tosti A, Ohyama M, Brogan Y, Yu G, Sontag A, Somani N. Understanding eyebrow and eyelash involvement in patients with alopecia areata and responsiveness to treatment with baricitinib. British Journal Of Dermatology 2025, 193: 240-249. PMID: 40179237, DOI: 10.1093/bjd/ljaf088.Peer-Reviewed Original ResearchBaricitinib 4 mgBaricitinib 2 mgHair-bearing sitesAlopecia areataResponse rateBenefit of baricitinibTreated with baricitinibRandomised to placeboPlacebo-controlled trialResponse to treatmentScalp hair lossSALT scoreDouble-blindClinical presentationBaricitinib treatmentTreatment successHair regrowthBaricitinibBaseline severityPatientsClinician reportsHair lossPlaceboPooled dataScalpBaricitinib and oral minoxidil for the treatment of alopecia areata in pediatric patients
Valido K, Craiglow B. Baricitinib and oral minoxidil for the treatment of alopecia areata in pediatric patients. Journal Of The American Academy Of Dermatology 2025, 93: 509-510. PMID: 40185280, DOI: 10.1016/j.jaad.2025.03.085.Peer-Reviewed Original ResearchGuest Editor's Note
Craiglow B. Guest Editor's Note. Pediatric Dermatology 2025, 42: 4-4. PMID: 40044618, DOI: 10.1111/pde.15861.Peer-Reviewed Original ResearchSystemic Therapies for Pediatric Alopecia Areata
Kalil L, Welch D, Heath C, Craiglow B. Systemic Therapies for Pediatric Alopecia Areata. Pediatric Dermatology 2025, 42: 36-42. PMID: 40044621, DOI: 10.1111/pde.15822.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAlopecia areataSystemic therapyPediatric alopecia areataAutoimmune hair loss disorderJanus kinase inhibitorsHair loss disorderComorbid atopyOral minoxidilLong-term useSystemic corticosteroidsTopical therapySystemic treatmentPediatric AACase reportAdjunctive treatmentMild diseaseKinase inhibitorsImmunomodulatory medicinesTherapyExtensive involvementAdverse effectsNarrative reviewAreataPatientsTreatment